in view of the dose-dependent relationship between estrogen and these two clotting factors , especially viic , it is likely that the effects of oral contraceptive usage on the risk for thromboembolism are mediated substantially through the level of coagulability .
C0014939
estrogen
C0040038
thromboembolism